The Fund’s objective is to achieve growth by investing primarily in equity securities of companies engaged in nutrition, nutraceuticals and new forms of medicines and pharmaceutical solutions.
The Fund will invest in a portfolio of companies that are listed on North American exchanges that have a business strategy focused on new and alternative health and wellness related themes that are growing in acceptance and importance in North America. This includes pharmaceutical companies; nutritional vitamins and supplement companies, health and wellness service providers; businesses engaged in providing diet and weight loss programs; alternative healthcare service providers; Canadian licensed producers of marijuana and related service providers; as well as companies involved in the processing, marketing and distribution of organic food and beverage products.
As a result, the Fund is designed to ensure that its portfolio is well diversified and to reduce the Fund’s concentration in any one security.
The majority of the securities are expected to have:
|MTD††||YTD %††||1 YR %||3 YR %||5 YR %||10 YR %||Inception %|
With the legalization of cannabis, the industry is anticipating high growth in medical and recreational use. Canadian licensed producers of medical cannabis are best positioned to benefit from legislative changes in the global market.
The combined medical and recreational market for cannabis in the next 5-7 years is expected to be $7 to $10 billion. Rivalling the liquor spirits and beer industries in Canada.
What are nutraceuticals?
Nutraceuticals are nutrients derived from food that may provide health or medicinal benefits, including the prevention and treatment of illness and disease. Examples include multivitamins and dietary supplements like probiotics.
Active management helps to reduce the risk of investing in the volatile cannabis sector by tactically allocating to nutraceutical, organics and other health and wellness sectors.
The flexibility of active management will help investors:
Ninepoint Alternative Health Fund is sub-advised by Faircourt Asset Management Inc. Faircourt was founded in 2002 and has established a reputation for innovative investment solutions.
|Fund Type||Sector Equity|
|Inception Date||March 26, 2017 (Series A)
August 8, 2017 (Series F)
|Registered Tax Plan Status||Eligible|
|Management Fee||Series A: 2.25%
Series F: 1.25%
|Minimum Initial Investment||$500|
|Minimum Subsequent Investment||$25|
|Minimum Investment Term||20 days (1.5% penalty)|